| 注册
首页|期刊导航|世界中医药|抗耐甲氧西林金黄色葡萄球菌药物的研究进展

抗耐甲氧西林金黄色葡萄球菌药物的研究进展

徐霄龙 郭玉红 赵京霞 何莎莎 刘清泉

世界中医药2016,Vol.11Issue(10):1955-1960,6.
世界中医药2016,Vol.11Issue(10):1955-1960,6.DOI:10.3969/j.issn.1673-7202.2016.10.005

抗耐甲氧西林金黄色葡萄球菌药物的研究进展

Research Progress in Study of Anti-MRSA Medicine

徐霄龙 1郭玉红 2赵京霞 3何莎莎 1刘清泉2

作者信息

  • 1. 首都医科大学附属北京中医医院,北京,100010
  • 2. 中医感染性疾病基础研究北京市重点实验室,北京,100010
  • 3. 北京市中医研究所,北京,100010
  • 折叠

摘要

Abstract

In recent years ,several kinds of pre-clinical and clinical molecule medicine were organized into categories with different regulating mechanisms and therapeutic effects on methicillin resistant Staphylococcus aureus ( MRSA) .And the number of studies on active constituent in Chinses material medica is growing , and indicated that large amount of Chinese material medica inhibited growth of drug-resistance bacteria both in component and by using separately , to prevent resistant mechanism and the evolution of the bacteria .The purpose of this review was to discuss the mechanisms of molecules currently and Chinese material medica on anti -MRSA properties via analysis .

关键词

新型抗菌药/中药/抗MRSA/逆转耐药

Key words

Novel antibacterial agents/Chinese metrial medica/Anti-MRSA/Reversal of drug resistance

分类

医药卫生

引用本文复制引用

徐霄龙,郭玉红,赵京霞,何莎莎,刘清泉..抗耐甲氧西林金黄色葡萄球菌药物的研究进展[J].世界中医药,2016,11(10):1955-1960,6.

基金项目

国家科技重大专项(编号:2013ZX09102026) (编号:2013ZX09102026)

国家自然科学基金项目(编号:81603364) (编号:81603364)

世界中医药

OACHSSCDCSTPCD

1673-7202

访问量0
|
下载量0
段落导航相关论文